Mignon Loh, Elizabeth Swisher named deputy directors at Fred Hutch/UW Cancer Consortium

Dewpoint Therapeutics and ConcertAI form drug development partnership

Dewpoint Therapeutics and ConcertAI announced the first phase of their Translational Oncology partnership, aligned around Dewpoint’s latest drug candidate, DPTX3186.

December 13, 2024

Vol.50 No.46

In Brief

Nicole Fleming joins Fred Hutch as deputy CMO

Nicole D. Fleming has joined Fred Hutch Cancer Center as the new deputy chief medical officer. Fleming brings expertise as a doctor, surgeon, researcher, administrator, mentor, and mother of three school-age children that fits well with the mission of a recently merged organization coping with growing pains.

November 15, 2024

Vol.50 No.43

In Brief

Fred Hutch receives $2M gift to endow the Bob and Pat Herbold Computational Biology Endowed Chair

Fred Hutchinson Cancer Center received a $2 million gift from philanthropists Bob and Pat Herbold to create the Bob and Pat Herbold Computational Biology Endowed Chair.

November 15, 2024

Vol.50 No.43

In Brief

Fred Hutch, UW, and Seattle Children’s consortium researchers receive $1.7M from Breast Cancer Research Foundation

Six Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium scientists received $1.7M in grants from Breast Cancer Research Foundation to launch or continue studies aimed at improving outcomes in breast cancer.

November 15, 2024

Vol.50 No.43

Clinical Roundup

Engineered HSV can trigger genetic chain reaction, rearrange HSV genes during co-infection

In preclinical work recently published in Nature Communications, Fred Hutchinson Cancer Center scientists used a genetic “chain reaction” to transform herpes simplex virus DNA during an HSV infection.

November 15, 2024

Vol.50 No.43

Drugs & Targets

Humana and Evolent expand partnership to enhance oncology care

Humana Inc. and Evolent Health Inc. announced an expansion of their strategic medical oncology partnership to modernize and streamline prior authorization processes to include radiation and surgical oncology services.

November 15, 2024

Vol.50 No.43

Mignon Loh, Elizabeth Swisher named deputy directors at Fred Hutch/UW Cancer Consortium

YOU MAY BE INTERESTED IN

Dewpoint Therapeutics and ConcertAI form drug development partnership

Nicole Fleming joins Fred Hutch as deputy CMO

Fred Hutch receives $2M gift to endow the Bob and Pat Herbold Computational Biology Endowed Chair

Fred Hutch, UW, and Seattle Children’s consortium researchers receive $1.7M from Breast Cancer Research Foundation

Engineered HSV can trigger genetic chain reaction, rearrange HSV genes during co-infection

Humana and Evolent expand partnership to enhance oncology care

Renew today!

Subscriber content

Never miss an issue!

Login